Jushi President Erich Mauff Shares Opportunities in American Marijuana Market
Our goal here is to ensure investors have access to insights they can’t find anywhere else.
This is vital because we’re at the dawn of new multibillion-dollar industries.
From humble and turbulent beginnings, the American cannabis market is projected to be worth $80 billion by 2030.
Meanwhile, sales of CBD products are estimated to top more than $20 billion in less than two years.
For companies with market caps largely measured in the hundreds of millions, cannabis and CBD are enormous opportunities.
This is why every cannabis company is racing to ensure it has both pieces at the core of its business.
And I recently talked to a rising star doing just that.
Nearly two years ago, Jushi Holdings (OTC: JUSHF) was founded by Erich Mauff and his partners, Jim Cacioppo, Jon Barack and Denis Arsenault.
Together, they have more than a century of combined merger and acquisition, private equity, and distressed and special investment experience.
The multistate cannabis and hemp operator has a two-pronged approach to growth: target adult-use markets and limited-license medical markets.
This is a cannabis and CBD company on the upswing.
Already, Jushi has raised $138 million in capital. It has licenses for up to 25 retail locations, two cultivation sites, and three extraction and processing facilities across nine states. And it has operations up and running in Nevada, New York and Pennsylvania.
On top of this, the company was recently added to the Horizons Emerging Marijuana Growers Index (NEO: HMJR).
Mauff sat down with me to share his insights on some of the biggest obstacles facing American cannabis – like the vaping crisis gripping the country – as well as some legislation that could turn the tide.
He also delved into the opportunities he sees on the horizon, particularly in oft-overlooked markets such as New York and Pennsylvania.
We want our investors, readers and viewers to hear directly from cannabis executives about issues pressing the industry. And this is a perfect opportunity.
Here’s to high returns,
How Cannabis Companies Are Faring in the Wake of the Pandemic
August 18, 2020
Why Medical Cannabis Advocates Are Still Battling
January 30, 2020